Latest News & Features
Refine Search
Europe
 For startups, getting a drug to market is a marathon but founders need to think beyond filing patents to win over investors, Marisa Woutersen explores how they can succeed.   10 July 2025 
Americas
 Disputed drug forms part of a multi-billion dollar franchise for J&J, ranking among its largest revenue drivers in mental health treatment | Appeals court rejects arguments that patent claims would have been obvious to a relevant artisan.   10 July 2025 
Careers
 The new partner brings more than 30 years’ experience, including in counselling pharmaceutical, life sciences, and medical device companies.   10 July 2025 
Americas
 LSPN panellists from Mathys & Squire discuss recent developments affecting the EPO Boards of Appeal and decisions emerging from the newly-formed Unified Patent Court. The session examines the implications for pan-European patent strategy.   10 July 2025 
Americas
 California medical device company sues rival at the ITC and in Delaware court over “copycat” brain monitoring system launch in May | Ceribell accuses competitor of “a history of willful patent infringement”.   9 July 2025 
Biotechnology
 LSPN brings together experts from Venable, Ipsen, Stoke Therapeutics, and Biogen to analyse best practices for IP transactions, from due diligence and valuation to structuring deals.   8 July 2025 
Europe
 Office declined application, citing earlier authorisations for inhalers designed for people  containing the same ingredient | Boehringer argued that ciclesonide was a ‘new active substance’ not previously authorised for a veterinary product in the EU.   8 July 2025 
Americas
 New addition expected to strengthen firm’s foundational ‘IP’ practice in Palo Alto.   8 July 2025 
Americas
 German and Finnish pharma giants sue Indian rival in Delaware court | Dispute centres on generic bid for prostate cancer blockbuster | Suit follows leadership shakeup at Bayer.   8 July 2025 
Europe
 The architect of an historic change in the way patent claims are interpreted explains what it means for AI drafting, and why more harmonisation may follow, reports Tom Phillips   3 July 2025 


